Member Directory
QMB is the largest purpose-built space in London for companies in science and technology, and the only centre to offer follow-on growth space for companies emerging from incubator space.. . Accommodation is available in flexible suite sizes from 500 square feet with flexible competitively-priced leases to other London based offerings. The flexibility of the centre means space can be easily reconfigured in response to meet a tenant's needs.
Queen May Innovation Ltd (QMI), is the wholly owned technology transfer subsidiary of Queen Mary, University of London. QMI is responsible for identifying, protecting and commercialising novel technologies in medicine and dentistry, healthcare, science and engineering. QMI manages a large and varied portfolio of licensed technologies and spin-out companies. With around 16,900 students, 3800 staff and an annual turnover of £300m, we are one of the biggest University of London colleges. The London School of Medicine and Dentistry faculty focuses on: translational research, cancer, cardiac, dentistry, inflammation, endocrinology/metabolism, immunology and infectious diseases, genomics, neuroscience, gastroenterology, epidemiology and primary care.
The Business Development Office provides access to Queen Mary University of London cutting-edge capabilities and state-of–the-art facilities. Our team of Business Development Managers will identify relevant academic expertise to meet your commercial requirements through collaborative research, contract research and consultancy.
Quotient Sciences are dedicated to accelerating the development of new drugs for patients around the world. They provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via their Translational Pharmaceutics® platform.. . For more than 30 years, Quotient Sciences has brought innovation to early drug development programs for pharmaceutical companies worldwide. At the company’s purpose built facilities, real-time manufacturing of all types of dosage forms is co-located with its clinical pharmacology unit to maximise flexibility, speed and cost savings for clients.
With a client base representing companies from the FT Global 500 and FTSE listed companies, Reddie & Grose is recognised as a leading patent and trade mark firm. In 2009, the Managing Intellectual Property global patent survey ranked the firm as one of the UK’s top patent prosecution advisors. It consistently continues to achieve high rankings in all professional surveys.. . Reddie & Grose prides itself on delivering intellectual property protection for businesses in both the domestic and international marketplaces with a strong professional team of over 30 people from varied scientific backgrounds.. . The firm’s Cambridge office offers particular expertise in biotechnology, pharmaceutical, chemical, engineering, cleantech, instrumentation, medical device, materials, and software related inventions. Companies/academic institutions represented in this field by Reddie & Grose include: Diagnostics for the Real World, Haemostatix, Funxional Therapeutics, TCP Innovations, Trillion Genomics, Brax, Cambridge Biopolymers, Metalysis, University of Cambridge, Cambridge Broadband, i2, Cambridge Biotechnology Ltd and nCipher.. . Talk to us...
Watch our webinar with One Nucleus 'What are the IP Challenges at the Intersection of Life Sciences, Technology and Engineering Disciplines?' https://youtu.be/OHM3IoLoJ0Q
In the early 1960s REED pioneered specialist recruitment services, a move which fundamentally changed the UK recruitment market. Today, with over 30 specialist recruitment divisions, the provision of temporary and permanent staff remains a core focus for REED.. . Reed Scientific specialised in supporting the Biotechnology, Chemicals, Food Technology, Pharmaceutical and Clinical markets. With 4 regional offices, Reed Scientific have the strength of a local presence coupled to an international support structure that allows them to fill permanent, temporary and interim vacancies with high calibre candidates.. . Our mission is to be the world's best recruiter, through constant innovation and continuous improvement.. . We will achieve our mission by living our values each day and working as one company, with global ambition:. . We are fair, open and honest -. We treat everyone with fairness and respect We act with integrity We are true to our commitments. . We take ownership -. We respond swiftly to execute our promises We take responsibility for providing solutions We hold ourselves accountable for our actions. . We work together -. We work in partnership and build sustainable trust relationships We value a diverse workforce and respect the contributions of all We support our customers and colleagues in achieving their goals.
Replica Biomaterials is a biotechnology company developing next-gen materials to meet demand for products that are environmentally sustainable and that do not harm animals.
Restore Harrow Green is a specialist in laboratory logistics and delivers a wide range of expert services including project management, ground transportation, packing and casing, handling confidential laboratory data, cleanroom relocation and the transfer of hazardous material.
Our highly skilled and trained teams have the expertise required to handle every aspect of a laboratory relocation from chemicals, research samples and sensitive data to refrigerated components, instruments, tools and precision equipment. Whether you’re moving a single instrument, a priceless sample or planning a complex large scale relocation in the UK or overseas, our track record, skills and regulatory adherence makes us the first choice trusted partner in laboratory logistics.
We have insight and knowledge which has grown through a deep understanding of our Life Sciences and Healthcare customers and over 35 years of supporting organisations in the planning, implementation and delivery of laboratory relocations and instrument transportation.
Horizon Discovery Group plc, a UK headquartered global life science company, is a world leader in gene editing and gene modulation. Through the application of these technologies the Company enables researchers to alter almost any gene or modulate its function in human or mammalian cells to generate models that mimic the genetic abnormalities found in diseases such as cancer. Horizon offers a catalogue of over 1,000,000 cell and reagent products, which along with related research services, support a greater understanding of the function of genes across all species and the genetic drivers of disease, and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, and are used in the Company’s own R&D pipeline.. . Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange’s AIM market under the ticker “HZD”. www.horizondiscovery.com . . •